LYEL
Price
$0.47
Change
-$0.01 (-2.08%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
135.86M
19 days until earnings call
PRME
Price
$1.75
Change
-$0.03 (-1.69%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
221.66M
15 days until earnings call
Ad is loading...

LYEL vs PRME

Header iconLYEL vs PRME Comparison
Open Charts LYEL vs PRMEBanner chart's image
Lyell Immunopharma
Price$0.47
Change-$0.01 (-2.08%)
Volume$17.99K
Capitalization135.86M
Prime Medicine
Price$1.75
Change-$0.03 (-1.69%)
Volume$25.38K
Capitalization221.66M
LYEL vs PRME Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. PRME commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongBuy and PRME is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (LYEL: $0.48 vs. PRME: $1.76)
Brand notoriety: LYEL and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 78% vs. PRME: 182%
Market capitalization -- LYEL: $135.86M vs. PRME: $221.66M
LYEL [@Biotechnology] is valued at $135.86M. PRME’s [@Biotechnology] market capitalization is $221.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 3 bearish.
  • PRME’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than PRME.

Price Growth

LYEL (@Biotechnology) experienced а +8.88% price change this week, while PRME (@Biotechnology) price change was +41.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 06, 2025.

PRME is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($222M) has a higher market cap than LYEL($136M). LYEL YTD gains are higher at: -25.313 vs. PRME (-39.726). PRME (-196.34M) and LYEL (-200.64M) have comparable annual earnings (EBITDA) . LYEL has more cash in the bank: 371M vs. PRME (190M). PRME has less debt than LYEL: PRME (40.8M) vs LYEL (59M). PRME has higher revenues than LYEL: PRME (2.98M) vs LYEL (61K).
LYELPRMELYEL / PRME
Capitalization136M222M61%
EBITDA-200.64M-196.34M102%
Gain YTD-25.313-39.72664%
P/E RatioN/AN/A-
Revenue61K2.98M2%
Total Cash371M190M195%
Total Debt59M40.8M145%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
58

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELPRME
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHIX30.44N/A
N/A
Artisan International Institutional
MGFZX8.77N/A
N/A
MassMutual Global I
WSCRX29.15N/A
N/A
Allspring Small Company Growth R6
MSDOX11.87N/A
N/A
Morgan Stanley Emerging Mkt ex China C
JDSAX19.86N/A
N/A
Janus Henderson Small Cap Value A

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+3.91%
VCYT - LYEL
46%
Loosely correlated
+1.08%
PRME - LYEL
45%
Loosely correlated
+4.14%
CRBU - LYEL
44%
Loosely correlated
+0.79%
RCKT - LYEL
44%
Loosely correlated
+2.44%
NTLA - LYEL
42%
Loosely correlated
-2.65%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+4.14%
CRSP - PRME
63%
Loosely correlated
-1.76%
RXRX - PRME
59%
Loosely correlated
-0.89%
BEAM - PRME
58%
Loosely correlated
+3.87%
NTLA - PRME
57%
Loosely correlated
-2.65%
ABCL - PRME
53%
Loosely correlated
+0.79%
More